Common Contracts
9 similar Underwriting Agreement contracts by Vse Corp, 9 Meters Biopharma, Inc., 2seventy Bio, Inc., others
VSE Corporation Common Stock, par value $0.05 per share Underwriting AgreementUnderwriting Agreement • October 17th, 2024 • Vse Corp • Services-engineering services
VSE Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom Jefferies LLC and RBC Capital Markets, LLC are acting as representatives (the “Representatives” or “you”) an aggregate of 1,724,137 shares (the “Firm Securities”) and, at the election of the Underwriters, up to 258,620 additional shares (the “Optional Securities”) of common stock, par value $0.05 per share (the “Common Stock”), of the Company (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Securities”).
Permian Resources Corporation 26,500,000 Shares of Class A Common Stock, par value $0.0001 per share Underwriting AgreementUnderwriting Agreement • July 30th, 2024 • Permian Resources Corp • Crude petroleum & natural gas
Permian Resources Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 26,500,000 shares (the “Shares”) of Class A Common Stock, par value $0.0001 per share (“Stock”), of the Company. To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representative as used herein shall mean you, as Underwriters, and the terms Representative and Underwriters shall mean either the singular or plural as the context requires.
VSE Corporation Common Stock, par value $0.05 per share Underwriting AgreementUnderwriting Agreement • May 17th, 2024 • Vse Corp • Services-engineering services
VSE Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom Jefferies LLC, RBC Capital Markets, LLC and William Blair & Company, L.L.C. are acting as representatives (the “Representatives” or “you”) an aggregate of 2,112,676 shares (the “Firm Securities”) and, at the election of the Underwriters, up to 316,901 additional shares (the “Optional Securities”) of common stock, par value $0.05 per share (the “Common Stock”), of the Company (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Securities”).
VSE Corporation Common Stock, par value $0.05 per share Underwriting AgreementUnderwriting Agreement • July 24th, 2023 • Vse Corp • Services-engineering services
VSE Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom RBC Capital Markets, LLC and William Blair & Company, L.L.C. are acting as representatives (the “Representatives” or “you”) an aggregate of 2,475,000 shares (the “Firm Securities”) and, at the election of the Underwriters, up to 371,250 additional shares (the “Optional Securities”) of common stock, par value $0.05 per share (the “Common Stock”), of the Company (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Securities”).
2seventy bio, Inc. Common Stock Underwriting AgreementUnderwriting Agreement • March 1st, 2023 • 2seventy Bio, Inc. • Pharmaceutical preparations
2seventy bio, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 10,869,566 shares (the “Firm Shares”) and, at the election of the Underwriters, up to additional 1,630,434 shares (the “Optional Shares”) of common stock, $0.0001 par value per share (“Stock”), of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
Societal CDMO, Inc. Common Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • December 13th, 2022 • Societal CDMO, Inc. • Pharmaceutical preparations
Societal CDMO, Inc., a Pennsylvania corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”), for whom RBC Capital Markets, LLC is acting as representative (the “Representative” or “you”) an aggregate of 27,841,737 shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company (the “Securities”).
LUMIRADX LIMITED Common Shares, par value $0.0000028 per common share Underwriting AgreementUnderwriting Agreement • July 19th, 2022 • LumiraDx LTD • Pharmaceutical preparations • New York
LumiraDx Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”), an aggregate of [●] common shares (the “Firm Shares”) and, at the election of the Underwriters, up to [●] additional common shares (the “Optional Shares”), par value $0.0000028 per common share (“Common Shares”), of the Company. The Firm Shares and the Optional Shares, that the Underwriters elect to purchase pursuant to Section 2 hereof, are herein collectively called the “Shares.”
Common Stock, par value $0.0001 per share Underwriting AgreementUnderwriting Agreement • April 5th, 2021 • 9 Meters Biopharma, Inc. • Pharmaceutical preparations • New York
The Company understands that the Underwriters propose to make a public offering of their respective portions of the Securities as soon as you deem advisable.
Common Stock, par value $0.0001 per share Underwriting AgreementUnderwriting Agreement • December 15th, 2020 • 9 Meters Biopharma, Inc. • Pharmaceutical preparations • New York
The Company understands that the Underwriters propose to make a public offering of their respective portions of the Securities as soon as you deem advisable.
